Casimir Jones, S.C.
Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
Provided herein are compositions, systems, kits, and methods for treating nervous system injuries caused by trauma or neurodegeneration or aging in a subject by administering a CSPG or SOCS3 reduction peptide (CRP and SRP respectively), or a nucleic acid sequence encoding the CRP or SRP, wherein both the CRP and SRP comprise a cell membrane penetrating domain, and a lysosome targeting domain, and the CRP further comprises a chondroitin sulfate proteoglycan (CSPG) binding domain, and the SRP further comprises a suppressor of cytokine signaling-3 (SOCS3) binding domain.
The Cleveland Clinic Foundation
A A C A A A A G C C A A A A C A A A G A C A A C A A C A A C A C A A A C A
A61K A61K C07K A61K A61P A61K A61K G01N C07K C12N A61K A61K A61K A61K C07K A61K A61L A61K G01N A61L C12Y A61K A61K C07K A61L A61L C07K A61K A61K C07K A61K C07K A61K A61P A61P C07K A61K
additional inventional additional additional inventional additional additional additional inventional inventional additional additional additional inventional additional additional additional additional additional additional inventional additional additional additional additional additional additional additional additional inventional additional additional additional inventional additional additional inventional
Ching-Yi Yu-Shang
Lin Lee